McAllister, K. A. et al. Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat. Genet. 8, 345–351 (1994).

Article  CAS  PubMed  Google Scholar 

Johnson, D. W. et al. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat. Genet. 13, 189–195 (1996).

Article  CAS  PubMed  Google Scholar 

Gallione, C. J. et al. A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet 363, 852–859 (2004).

Article  CAS  PubMed  Google Scholar 

Balachandar, S. et al. Identification and validation of a novel pathogenic variant in GDF2 (BMP9) responsible for hereditary hemorrhagic telangiectasia and pulmonary arteriovenous malformations. Am. J. Med. Genet. A 188, 959–964 (2022).

Article  CAS  PubMed  Google Scholar 

Wooderchak-Donahue, W. L. et al. BMP9 mutations cause a vascular-anomaly syndrome with phenotypic overlap with hereditary hemorrhagic telangiectasia. Am. J. Hum. Genet. 93, 530–537 (2013).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Goumans, M.-J., Zwijsen, A., Ten Dijke, P. & Bailly, S. Bone morphogenetic proteins in vascular homeostasis and disease. Cold Spring Harb. Perspect. Biol. 10, a031989 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Shovlin, C. L. et al. Updates on diagnostic criteria for hereditary haemorrhagic telangiectasia in the light of whole genome sequencing of ‘gene-negative’ individuals recruited to the 100000 Genomes Project. J. Med. Genet. 61, 182–185 (2024).

Article  CAS  PubMed  Google Scholar 

Shovlin, C. L. et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu–Osler–Weber syndrome). Am. J. Med. Genet. 91, 66–67 (2000).

Article  CAS  PubMed  Google Scholar 

Zhang, E., Virk, Z. M., Rodriguez-Lopez, J. & Al-Samkari, H. Hereditary hemorrhagic telangiectasia may be the most morbid inherited bleeding disorder in women. Blood Adv. 8, 3166–3172 (2024).

Article  PubMed  PubMed Central  Google Scholar 

Kelly, C., Buscarini, E., Manfredi, G., Gregory, S. & Heneghan, M. A. Hepatic manifestations of hereditary haemorrhagic telangiectasia. Liver Int. 44, 2220–2234 (2024).

Article  CAS  PubMed  Google Scholar 

Krings, T. et al. Neurovascular phenotypes in hereditary haemorrhagic telangiectasia patients according to age. Review of 50 consecutive patients aged 1 day–60 years. Neuroradiology 47, 711–720 (2005).

Article  CAS  PubMed  Google Scholar 

Kjeldsen, A. D., Vase, P. & Green, A. Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients. J. Intern. Med. 245, 31–39 (1999).

Article  CAS  PubMed  Google Scholar 

Plauchu, H., de Chadarévian, J. P., Bideau, A. & Robert, J. M. Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am. J. Med. Genet. 32, 291–297 (1989).

Article  CAS  PubMed  Google Scholar 

Lesca, G. et al. Hereditary hemorrhagic telangiectasia: evidence for regional founder effects of ACVRL1 mutations in French and Italian patients. Eur. J. Hum. Genet. 16, 742–749 (2008).

Article  CAS  PubMed  Google Scholar 

Dakeishi, M. et al. Genetic epidemiology of hereditary hemorrhagic telangiectasia in a local community in the northern part of Japan. Hum. Mutat. 19, 140–148 (2002).

Article  CAS  PubMed  Google Scholar 

Serra, M. M., Papi, M. & Serrano, C. Prevalence of hereditary hemorrhagic telangiectasia in a medical care program organization in Buenos Aires, Argentina. Medicina 84, 221–226 (2024).

PubMed  Google Scholar 

Donaldson, J. W., McKeever, T. M., Hall, I. P., Hubbard, R. B. & Fogarty, A. W. Complications and mortality in hereditary hemorrhagic telangiectasia: a population-based study. Neurology 84, 1886–1893 (2015).

Article  PubMed  PubMed Central  Google Scholar 

McDonald, J. et al. Frequency of epistaxis and telangiectasia in patients with hereditary hemorrhagic telangiectasia (HHT) in comparison with the general population: Curaçao diagnostic criteria revisited. Genet. Med. 25, 100865 (2023).

Article  CAS  PubMed  Google Scholar 

Kilian, A. et al. Genotype–phenotype correlations in children with HHT. J. Clin. Med. 9, 2714 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Faughnan, M. E. et al. Second international guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia. Ann. Intern. Med. 173, 989–1001 (2020).

Article  PubMed  Google Scholar 

Shovlin, C. L. et al. British Thoracic Society clinical statement on pulmonary arteriovenous malformations. Thorax 72, 1154–1163 (2017).

Article  PubMed  Google Scholar 

European Association for the Study of the Liver. EASL clinical practice guidelines: vascular diseases of the liver. J. Hepatol. 64, 179–202 (2016).

Article  Google Scholar 

Eker, O. F. et al. European Reference Network for Rare Vascular Diseases (VASCERN) position statement on cerebral screening in adults and children with hereditary haemorrhagic telangiectasia (HHT). Orphanet J. Rare Dis. 15, 165 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Shovlin, C. L. et al. The European Rare Disease Network for HHT Frameworks for management of hereditary haemorrhagic telangiectasia in general and speciality care. Eur. J. Med. Genet. 65, 104370 (2022).

Article  CAS  PubMed  Google Scholar 

Dupuis-Girod, S. et al. European Reference Network for Rare Vascular Diseases (VASCERN): when and how to use intravenous bevacizumab in hereditary haemorrhagic telangiectasia (HHT)? Eur. J. Med. Genet. 65, 104575 (2022).

Article  CAS  PubMed  Google Scholar 

Thompson, K. P. et al. Predictors of mortality in patients with hereditary hemorrhagic telangiectasia. Orphanet J. Rare Dis. 16, 12 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kjeldsen, A., Aagaard, K. S., Tørring, P. M., Möller, S. & Green, A. 20-year follow-up study of Danish HHT patients—survival and causes of death. Orphanet J. Rare Dis. 11, 157 (2016).

Article  PubMed  PubMed Central  Google Scholar 

de Gussem, E. M. et al. Life expectancy of parents with hereditary haemorrhagic telangiectasia. Orphanet J. Rare Dis. 11, 46 (2016).

Article  PubMed  PubMed Central  Google Scholar 

Droege, F. et al. Life expectancy and comorbidities in patients with hereditary hemorrhagic telangiectasia. Vasc. Med. 23, 377–383 (2018).

Article  PubMed  Google Scholar 

Duarte, C. W. et al. Improved survival outcomes in cancer patients with hereditary hemorrhagic telangiectasia. Cancer Epidemiol. Biomark. Prev. 23, 117–125 (2014).

Article  CAS  Google Scholar 

Hosman, A. E., Devlin, H. L., Silva, B. M. & Shovlin, C. L. Specific cancer rates may differ in patients with hereditary haemorrhagic telangiectasia compared to controls. Orphanet J. Rare Dis. 8, 195 (2013).

Article  PubMed  PubMed Central  Google Scholar 

Jain, K. et al. Pathogenic variant frequencies in hereditary haemorrhagic telangiectasia support clinical evidence of protection from myocardial infarction. J. Clin. Med. 13, 250 (2023).

Article  PubMed  PubMed Central